Records containing: Scleroderma, Systemic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22Prognostic Value of Trichoscopy in Patients With Systemic Scleroderma
-
CLINICAL_TRIALS study record update · 2026-04-15A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients With Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension (SSc-PAH)
-
CLINICAL_TRIALS study record update · 2026-03-27Scleroderma: Description of Functional Disability Between the Dominant and Contralateral Hand, a Single-centre Descriptive Cohort.
-
CLINICAL_TRIALS study record update · 2026-03-25SCLEROCAR: A Phase IIa Trial Evaluating the Efficacy of Anti-CD19 Chimeric Antigen Receptor Engineered T-Cells in Patients With Systemic Sclerosis (SSc) Resistant to Immunosuppressive Drugs
-
CLINICAL_TRIALS study record update · 2026-03-17A Phase II, Randomised, Placebo-controlled, Double-blind, Parallel Group, Efficacy and Safety Study of at Least 48 Weeks of Oral BI 685509 Treatment in Adults With Progressive Systemic Sclerosis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-16Efficacy of Tofacitinib on Skin Thickening in Diffuse Cutaneous Systemic Sclerosis: A Comparative Study With Methotrexate
-
CLINICAL_TRIALS study record update · 2026-01-23Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
-
CLINICAL_TRIALS study record update · 2026-01-15Western Sweden Systemic Sclerosis Project - A Study on Underlying Mechanisms for Disease Development and Predictors of Disease Activity and Treatment Response in Patients With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)
-
CLINICAL_TRIALS study record update · 2025-12-23Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
-
CLINICAL_TRIALS study record update · 2025-12-04Treatment of Digital Ulcers in Systemic Sclerosis With Diosmin: A Randomized, Double-blind, Placebo-controlled Multi-centre Pilot Study
-
CLINICAL_TRIALS study record update · 2025-04-06A Phase 2 Open-Label Pilot Study of the Safety and Tolerability of Ixazomib Administered Orally to Patients With Scleroderma-Related Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2025-02-13Evaluation of the Making it Work Program for Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2025-02-03A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of Bosentan in Patients With Interstitial Lung Disease Associated With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2024-12-04Phenotyping of Chronic Pain in Diffused Systemic Scleroderma: Characteristics and Perturbations of Mechanisms of Pain, Impact on the Quality of Life and Correlations of Fatigue, Sleeping Disorders and Mood or Anxiety Disorders
-
CLINICAL_TRIALS study record update · 2024-11-20Development and Evaluation of an Evidence-based Education Program for People With Hand Dysfunction in Scleroderma: A Randomized Control Trail
-
CLINICAL_TRIALS study record update · 2024-10-09A Multicenter, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Study of Guselkumab in Participants With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2024-09-19Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
-
CLINICAL_TRIALS study record update · 2024-06-27Identification and Characterization of microRNAs Involved in Esophageal, Gastric and Duodenal Fibrotic Manifestations of Systemic Scleroderma
-
CLINICAL_TRIALS study record update · 2024-05-22The Effect of Exercise Program Applied to Patients With Scleroderma on Functional Outcomes: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-03-05An Open-lable Trial of Subcutaneous Semaglutide in Systemic Scleroderma
-
CLINICAL_TRIALS study record update · 2023-12-20A Phase II, Randomised, Double Blind, Placebo-controlled Study of the Pharmacokinetics, Pharmacodynamic Effects, and Safety, of Oral FT011 in Participants With Diffuse Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2023-12-15Scleroderma Lung Study III (SLS III): Combining the Anti-fibrotic Effects of Pirfenidone (PFD) With Mycophenolate (MMF) for Treating Scleroderma-related Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2023-05-06The Development and Investigation of Effectiveness of Leap Motion Based Gamefication Exercises in Hand Rehabilitation of the Individuals With Systemic Sclerosis
-
CLINICAL_TRIALS study record update · 2023-05-06Pilot Study of descriPtion of cicatriSation Rates of Digital Ulcers in Systemic scleroDerma